SEC Form 4 filed by Qiming Corporate Gp Vi, Ltd.
| FORM 4 | UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
| |||||||||||||||
| Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b). | |||||||||||||||||
| Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10. | |||||||||||||||||
1. Name and Address of Reporting Person*
(Street)
(Country) | 2. Issuer Name and Ticker or Trading Symbol
Alamar Biosciences, Inc. [ ALMR ] | 5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
| |||||||||||||||||||||||||
| 2a. Foreign Trading Symbol
| |||||||||||||||||||||||||||
| 3. Date of Earliest Transaction
(Month/Day/Year) 04/20/2026 | 6. Individual or Joint/Group Filing (Check Applicable Line)
| ||||||||||||||||||||||||||
| 4. If Amendment, Date of Original Filed
(Month/Day/Year) |
| Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 1. Title of Security (Instr. 3) | 2. Transaction Date (Month/Day/Year) | 2A. Deemed Execution Date, if any (Month/Day/Year) | 3. Transaction Code (Instr. 8) | 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) | 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) | 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 7. Nature of Indirect Beneficial Ownership (Instr. 4) | |||
| Code | V | Amount | (A) or (D) | Price | ||||||
| Class B Common Stock | 04/20/2026 | C | 185,163 | A | (1)(2) | 185,163 | I | See footnote(3) | ||
| Class B Common Stock | 04/20/2026 | C | 6,881,410 | A | (1)(2) | 6,881,410 | I | See footnote(4) | ||
| Class B Common Stock | 04/20/2026 | C | 1,605,645 | A | (1) | 1,605,645 | I | See footnote(5) | ||
| Class B Common Stock | 04/20/2026 | C | 1,922,329 | A | (1) | 1,922,329 | I | See footnote(6) | ||
| Class B Common Stock | 04/20/2026 | J(7) | 185,163 | D | (7) | 0 | I | See footnote(3) | ||
| Class B Common Stock | 04/20/2026 | J(7) | 6,881,410 | D | (7) | 0 | I | See footnote(4) | ||
| Class B Common Stock | 04/20/2026 | J(7) | 1,605,645 | D | (7) | 0 | I | See footnote(5) | ||
| Class B Common Stock | 04/20/2026 | J(7) | 1,922,329 | D | (7) | 0 | I | See footnote(6) | ||
| Common Stock | 04/20/2026 | J(7) | 185,163 | A | (7) | 185,163 | I | See footnote(3) | ||
| Common Stock | 04/20/2026 | J(7) | 6,881,410 | A | (7) | 6,881,410 | I | See footnote(4) | ||
| Common Stock | 04/20/2026 | J(7) | 1,605,645 | A | (7) | 1,605,645 | I | See footnote(5) | ||
| Common Stock | 04/20/2026 | J(7) | 1,922,329 | A | (7) | 1,922,329 | I | See footnote(6) | ||
| Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. Title of Derivative Security (Instr. 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Transaction Date (Month/Day/Year) | 3A. Deemed Execution Date, if any (Month/Day/Year) | 4. Transaction Code (Instr. 8) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) | 6. Date Exercisable and Expiration Date (Month/Day/Year) | 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) | 8. Price of Derivative Security (Instr. 5) | 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) | ||||
| Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||||||
| Series A-3 Preferred Stock | (1) | 04/20/2026 | C | 172,328 | (1) | (1) | Class B Common Stock | 71,268 | $0 | 0 | I | See footnote(3) | |||
| Series A-3 Preferred Stock | (1) | 04/20/2026 | C | 6,404,332 | (1) | (1) | Class B Common Stock | 2,648,607 | $0 | 0 | I | See footnote(4) | |||
| Series A-4 Preferred Stock | (1) | 04/20/2026 | C | 154,425 | (1) | (1) | Class B Common Stock | 63,864 | $0 | 0 | I | See footnote(3) | |||
| Series A-4 Preferred Stock | (1) | 04/20/2026 | C | 5,738,971 | (1) | (1) | Class B Common Stock | 2,373,437 | $0 | 0 | I | See footnote(4) | |||
| Series B Preferred Stock | (2) | 04/20/2026 | C | 113,625 | (2) | (2) | Class B Common Stock | 50,031 | $0 | 0 | I | See footnote(3) | |||
| Series B Preferred Stock | (2) | 04/20/2026 | C | 4,222,738 | (2) | (2) | Class B Common Stock | 1,859,366 | $0 | 0 | I | See footnote(4) | |||
| Series C Preferred Stock | (1) | 04/20/2026 | C | 3,882,451 | (1) | (1) | Class B Common Stock | 1,605,645 | $0 | 0 | I | See footnote(5) | |||
| Series C Preferred Stock | (1) | 04/20/2026 | C | 4,648,194 | (1) | (1) | Class B Common Stock | 1,922,329 | $0 | 0 | I | See footnote(6) | |||
1. Name and Address of Reporting Person*
(Street)
Relationship of Reporting Person(s) to Issuer
| ||||||||||||||||||||||||||||
1. Name and Address of Reporting Person*
(Street)
Relationship of Reporting Person(s) to Issuer
| ||||||||||||||||||||||||||||
1. Name and Address of Reporting Person*
(Street)
Relationship of Reporting Person(s) to Issuer
| ||||||||||||||||||||||||||||
1. Name and Address of Reporting Person*
(Street)
Relationship of Reporting Person(s) to Issuer
| ||||||||||||||||||||||||||||
1. Name and Address of Reporting Person*
(Street)
Relationship of Reporting Person(s) to Issuer
| ||||||||||||||||||||||||||||
1. Name and Address of Reporting Person*
(Street)
Relationship of Reporting Person(s) to Issuer
| ||||||||||||||||||||||||||||
1. Name and Address of Reporting Person*
(Street)
Relationship of Reporting Person(s) to Issuer
| ||||||||||||||||||||||||||||
| Explanation of Responses: |
| 1. Each share of the Series A-3 Preferred Stock, Series A-4 Preferred Stock and Series C Preferred Stock converted into 0.4136 share of Class B Common Stock at the closing of the initial public offering. The Series A-3 Preferred Stock, Series A-4 Preferred Stock and Series C Preferred Stock had no expiration date. |
| 2. Each share of Series B Preferred Stock converted into 0.4403 share of Class B Common Stock at the closing of the initial public offering. The Series B Preferred Stock had no expiration date. |
| 3. These shares are held of record by Qiming Managing Directors Fund VI, L.P. ("Qiming Managing Directors"). Qiming Corporate GP VI, Ltd. ("Qiming Corporate") serves as the general partner of Qiming Managing Directors and may be deemed to have voting and dispositive power over the shares held by Qiming Managing Directors. Qiming Corporate disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein. |
| 4. These shares are held of record by Qiming Venture Partners VI, L.P., ("Qiming Venture Partners VI"). Qiming Corporate, through one intermediary, serves as the indirect general partner of Qiming Venture Partners VI and may be deemed to have voting and dispositive power over the shares held by Qiming Venture Partners VI. Qiming Corporate disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein. |
| 5. These shares are held of record by Qiming Venture Partners VIII Investments, LLC ("QVP VIII LLC"). Qiming GP VIII, LLC, through two parallel intermediaries, serves as the indirect general partner of QVP VIII LLC and may be deemed to have voting and dispositive power over the shares held by QVP VIII LLC. Qiming GP VIII, LLC disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein. |
| 6. These shares are held of record by Qiming Venture Partners VIII-HC, L.P. ("QVP VIII-HC"). Qiming GP VIII-HC, LLC serves as the general partner of QVP VIII-HC and may be deemed to have voting and dispositive power over the shares held by QVP VIII-HC. Qiming GP VIII-HC, LLC disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein. |
| 7. Each share of Class B Common Stock was automatically reclassified into one share of Common Stock immediately prior to the completion of the Issuer's initial public offering of Common Stock. |
| Qiming GP VIII, LLC By: /s/ Ho Man LAM/Authorized Signatory | 04/22/2026 | |
| Qiming Venture Partners VIII Investments, LLC By: /s/ Ho Man LAM/Manager | 04/22/2026 | |
| Qiming Corporate GP VI, Ltd By: /s/ Ho Man LAM/Authorized Signatory | 04/22/2026 | |
| Qiming Managing Directors Fund VI, L.P. By: /s/ Ho Man LAM/Authorized Signatory | 04/22/2026 | |
| Qiming Venture Partners VI, L.P. By: /s/ Ho Man LAM/Authorized Signatory | 04/22/2026 | |
| Qiming GP VIII-HC, LLC By: /s/ Ho Man LAM/Authorized Signatory | 04/22/2026 | |
| Qiming Venture Partners VIII-HC, L.P. By: /s/ Ho Man LAM/Authorized Signatory | 04/22/2026 | |
| ** Signature of Reporting Person | Date | |
| Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | ||
| * If the form is filed by more than one reporting person, see Instruction 4 (b)(v). | ||
| ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). | ||
| Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. | ||
| Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. | ||
| * Form 4: SEC 1474 (03-26) | ||